These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 8200278)

  • 1. [Specific cytotoxicity of recombinant interleukin 6-pseudomonas exotoxin fusion protein (IL6-PE40) on LT12 leukemic cells expressing high levels of interleukin 6 receptor (IL6R)].
    Xi YZ
    Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):419-22. PubMed ID: 8200278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular design and construction of IL6D24-PE40KDEL, a novel recombinant interleukin6-pseudomonas exotoxin fusion protein, having targeted cytotoxicity for leukemias expressing interleukin6 receptors].
    Zheng LY; Xi YZ; Kong FH; Cui JW; Liang F; Liu N; Sun YY; Guo SQ
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1246-50. PubMed ID: 12930640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of recombinant stem cell factor on the proliferation in vitro of LT12 acute promyelocytic leukemic cell line].
    Xi YZ; Martens AC; Zsebo KM
    Zhonghua Zhong Liu Za Zhi; 1994 Mar; 16(2):93-7. PubMed ID: 7523053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute myelocytic leukemia with interleukin-6 Pseudomonas exotoxin fusion protein in a rat leukemia model.
    Rozemuller H; Rombouts WJ; Touw IP; FitzGerald DJ; Kreitman RJ; Pastan I; Hagenbeek A; Martens AC
    Leukemia; 1996 Nov; 10(11):1796-803. PubMed ID: 8892684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of high-affinity interleukin 4 receptors on murine sarcoma cells and receptor-mediated cytotoxicity of tumor cells to chimeric protein between interleukin 4 and Pseudomonas exotoxin.
    Puri RK; Ogata M; Leland P; Feldman GM; FitzGerald D; Pastan I
    Cancer Res; 1991 Jun; 51(11):3011-7. PubMed ID: 2032239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of interleukin 6-Pseudomonas exotoxin chimeric molecules against the human hepatocellular carcinoma, PLC/PRF/5 in mice.
    Siegall CB; Kreitman RJ; FitzGerald DJ; Pastan I
    Cancer Res; 1991 Jun; 51(11):2831-6. PubMed ID: 1851660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity of IL6-PE40 and derivatives on tumor cells expressing a range of interleukin 6 receptor levels.
    Siegall CB; FitzGerald DJ; Pastan I
    J Biol Chem; 1990 Sep; 265(27):16318-23. PubMed ID: 2118904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-specific toxicity of a chimeric protein composed of interleukin-6 and Pseudomonas exotoxin (IL6-PE40) on tumor cells.
    Siegall CB; Nordan RP; FitzGerald DJ; Pastan I
    Mol Cell Biol; 1990 Jun; 10(6):2443-7. PubMed ID: 2160579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric acute myelogenous leukemia cells express IL-6 receptors and are sensitive to a recombinant IL6-Pseudomonas exotoxin.
    Boayue KB; Gu L; Yeager AM; Kreitman RJ; Findley HW
    Leukemia; 1998 Feb; 12(2):182-91. PubMed ID: 9519780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of interleukin-6 receptors by pediatric acute lymphoblastic leukemia cells with the t(4;11) translocation: a possible target for therapy with recombinant IL6-Pseudomonas exotoxin.
    Gu L; Zhou M; Jurickova I; Yeager AM; Kreitman RJ; Phillips CN; Findley HW
    Leukemia; 1997 Oct; 11(10):1779-86. PubMed ID: 9324301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective killing of IL6 receptor bearing myeloma cells using recombinant IL6-Pseudomonas toxin.
    Siegall CB; FitzGerald DJ; Pastan I
    Curr Top Microbiol Immunol; 1990; 166():63-9. PubMed ID: 2127396
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and characterization of interleukin-13 receptor in human medulloblastoma and targeting these receptors with interleukin-13-pseudomonas exotoxin fusion protein.
    Joshi BH; Leland P; Puri RK
    Croat Med J; 2003 Aug; 44(4):455-62. PubMed ID: 12950150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diphtheria toxin-epidermal growth factor fusion protein and Pseudomonas exotoxin-interleukin 13 fusion protein exert synergistic toxicity against human glioblastoma multiforme cells.
    Liu TF; Willingham MC; Tatter SB; Cohen KA; Lowe AC; Thorburn A; Frankel AE
    Bioconjug Chem; 2003; 14(6):1107-14. PubMed ID: 14624623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.
    Kioi M; Kawakami K; Puri RK
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6231-8. PubMed ID: 15448012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganciclovir-mediated in vivo elimination of myeloid leukemic cells expressing the HSVtk gene induces HSVtk loss variants.
    Braakman E; Vogels R; Martens AC; Vermeulen J; Bron M; Hoogerbrugge PM; Valerio D; Hagenbeek A
    Gene Ther; 1999 Jun; 6(6):1139-46. PubMed ID: 10455417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical and physical properties for a recombinant IL6 Pseudomonas exotoxin fusion protein IL6D24-PE40KDEL].
    Cui JW; Guo SQ; Sun YY; Liu N; Liang F; Xi YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):825-8. PubMed ID: 15631670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic activity of an interleukin 6-Pseudomonas exotoxin fusion protein on human myeloma cells.
    Siegall CB; Chaudhary VK; FitzGerald DJ; Pastan I
    Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9738-42. PubMed ID: 3264406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent receptor-mediated cytotoxicity of granulocyte colony-stimulating factor-Pseudomonas exotoxin, a fusion protein against myeloid leukemia cells.
    Oshima Y; Tojo A; Fujimura A; Niho Y; Asano S
    Biochem Biophys Res Commun; 2004 Jun; 319(2):582-9. PubMed ID: 15178446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The designer cytokine hyper-IL-6 mediates growth inhibition and GM-CSF-dependent rejection of B16 melanoma cells.
    Ozbek S; Peters M; Breuhahn K; Mann A; Blessing M; Fischer M; Schirmacher P; Mackiewicz A; Rose-John S
    Oncogene; 2001 Feb; 20(8):972-9. PubMed ID: 11314032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo.
    Yang D; Kuan CT; Payne J; Kihara A; Murray A; Wang LM; Alimandi M; Pierce JH; Pastan I; Lippman ME
    Clin Cancer Res; 1998 Apr; 4(4):993-1004. PubMed ID: 9563895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.